<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Silymarin consists of several flavonoid-like compounds extracted from the small hard fruits (kenguil seeds) of 
 <italic class="italic">Silybum marianum</italic> L. Gaertn (milk thistle), which grows extensively in Europe and Asia, including India. The drug belongs to a class of compounds—flavonolignans—likely produced in the plant by radical coupling of flavonoids and coniferyl alcohol [
 <xref rid="B16-molecules-24-02155" ref-type="bibr" class="xref">16</xref>]. A reference composition comprises: silybin or silibinin (33.4%), silychristin (12.9%), silydianin (3.5%) and isosilybin (8.35%) [
 <xref rid="B17-molecules-24-02155" ref-type="bibr" class="xref">17</xref>,
 <xref rid="B18-molecules-24-02155" ref-type="bibr" class="xref">18</xref>], which are assumed to be responsible for the therapeutic liver-protecting activity of the plant extract [
 <xref rid="B19-molecules-24-02155" ref-type="bibr" class="xref">19</xref>,
 <xref rid="B20-molecules-24-02155" ref-type="bibr" class="xref">20</xref>,
 <xref rid="B21-molecules-24-02155" ref-type="bibr" class="xref">21</xref>,
 <xref rid="B22-molecules-24-02155" ref-type="bibr" class="xref">22</xref>]. The silymarin composition and the ratios of individual constituents may vary with respect to different brands of commercial standardized milk thistle extracts [
 <xref rid="B23-molecules-24-02155" ref-type="bibr" class="xref">23</xref>].
</p>
